TITAN PHARMACEUTICALS INC 4
4 · TITAN PHARMACEUTICALS INC · Filed Aug 26, 2015
Insider Transaction Report
Form 4
TITAN PHARMACEUTICALS INCTTNP.OB
BHONSLE SUNIL
DirectorPresident
Transactions
- Purchase
Common Stock
2015-08-25$0.70/sh+50,000$34,800→ 481,500 total
Holdings
- 300,757(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]Represents the weighted average purchase price for the reported transactions. The range of prices for such transactions was $0.6799 to $0.70. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- [F2]The reporting person serves as trustee of the family trust.